The Global Health Body Issues Alert Over Critical Shortage of Weight-Loss Medications
Under a tenth of people that would benefit from weight-loss injections such as Wegovy are able to get them, states the global health agency as it publishes its initial guidance on the drugs.
Given more than one billion individuals worldwide now living with obesity, it is calling for more widespread and fairer access to GLP-1 medication.
Per forecasts, more than two billion could be living with obesity by 2030 unless action is taken.
"Our latest guidance acknowledges that obesity is a lifelong illness that can be managed with comprehensive and continuous treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and logistical bottlenecks are key barriers to broad access to the jabs that can assist patients in reducing considerable body mass, notes the agency.
GLP-1 Therapy Shortage
Despite the present best projected case, the production of such drugs might only reach approximately 100 million people – fewer than 10% of the global need, according to the health organization.
The guideline calls on nations and manufacturers to widen access, via measures including voluntary licensing.
The intellectual property rights on a key compound – the primary component of Novo Nordisk's Wegovy – is scheduled to end in a number of countries in 2026.
How Obesity Jabs Work
The injections imitate a body's own hormone to delay gastric emptying, curb appetite and increase feelings of fullness so people reduce food intake.
Individuals usually start to lose weight in the initial weeks of starting on the weekly injections.
Research indicates patients may regain a significant portion after a year of stopping the drug, because their normal hunger come back.
To be above a healthy weight increases your chance for contracting health problems, such as type 2 diabetes, cardiovascular issues, stroke, and some malignancies.
Excess weight concerns people in all nations and was responsible for millions of fatalities worldwide in 2024, as per the health agency.